# Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

> **NCT00975325** · PHASE4 · COMPLETED · sponsor: **Walter Ritter GmbH & Co** · enrollment: 42 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Yohimbine
- **DRUG:** Yohimbine

## Key facts

- **NCT ID:** NCT00975325
- **Lead sponsor:** Walter Ritter GmbH & Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2015-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975325, "Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00975325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*